AQUASFINX

Welcome to the Brand page for “AQUASFINX”, which is offered here for Aquiasfinx provides the discovery scientist with a set of integrated, automated platform modules capable of running up to 1,500 parallel conditions per day to identify pharmaceutically acceptable excipient mixtures to meet the challenge of delivery of poorly water soluble drugs for animal dosing this platform can be used in early discovery and lead optimization to provide a means of very rapidly entering poorly soluble drug candidates into animal dosing such studies can be used to determine if a compound is a potential drug candidate or simply a lead from which improved candidates can be elaborated;.

Its status is currently believed to be active. Its class is unavailable. “AQUASFINX” is believed to be currently owned by “TransForm Pharmaceuticals, Inc.”

Owner:
TRANSFORM PHARMACEUTICALS, INC.
Owner Details
Description:
AquiaSFinX provides the discovery scientist with a set of integrated, automated platform modules capable of running up to 1,500 parallel conditions per day to identify pharmaceutically acceptable excipient mixtures to meet the challenge of delivery of poorly water soluble drugs for animal dosing This platform can be used in early discovery and lead optimization to provide a means of very rapidly entering poorly soluble drug candidates into animal dosing Such studies can be used to determine if a compound is a potential drug candidate or simply a lead from which improved candidates can be elaborated;
Categories: AQUIASFINX PROVIDES DISCOVERY SCIENTIST